Annual report pursuant to Section 13 and 15(d)

Note R - Commitments and Other (Details Textual)

v3.19.1
Note R - Commitments and Other (Details Textual)
1 Months Ended 12 Months Ended
Jan. 01, 2005
Jan. 31, 2018
Dec. 31, 2018
USD ($)
ft²
Dec. 31, 2017
USD ($)
Advances on Inventory Purchases     $ 648,783 $ 697,192
Additional Percentage of Director Compensation on Sales Value Using Certain Specify Technology 2.50%      
Additional Percentage of Director Compensation Sales Value Using Other Kind of Technology 5.00%      
Area of Office Space | ft²     7,625  
Operating Leases, Rent Expense, Minimum Rentals     $ 12,522  
Director of Clinical Affairs [Member]        
Royalty Expense     465,000 554,000
Professional Fees     186,000 275,000
Accounts Payable, Related Parties     364,000 162,000
Director Clinical Affair [Member]        
Professional Fees     186,000 275,000
Accounts Payable, Related Parties     364,000 $ 162,000
Purchase Commitment for Devices [Member]        
Purchase Commitment Number Of Units   2,000    
Purchase Commitment, Remaining Minimum Amount Committed     873,400  
Advances on Inventory Purchases     596,724  
Purchase Obligation, Total     $ 259,801